How much did Bioton achieve in EBIT for the current year?
In the current year, Bioton has achieved an EBIT of 13.81 M PLN.
Bioton EBIT 2024
Bioton EBIT
13.81 M PLN
Ticker
BIO.WA
ISIN
PLBIOTN00029
WKN
A0D9SD
In 2024, Bioton's EBIT was 13.81 M PLN, a -50.54% increase from the 27.93 M PLN EBIT recorded in the previous year.
The Bioton EBIT history
| YEAR | EBIT (undefined PLN) |
|---|---|
| 2023 | 13.81 |
| 2022 | 27.93 |
| 2021 | 15.96 |
| 2020 | 30.24 |
| 2019 | -71.22 |
| 2018 | -50.52 |
| 2017 | 2.75 |
| 2016 | -10.83 |
| 2015 | 11.96 |
| 2014 | 21.77 |
| 2013 | 8.8 |
| 2012 | 66.5 |
| 2011 | -54.6 |
| 2010 | 48 |
| 2009 | -320.4 |
| 2008 | -32.1 |
| 2007 | 100.7 |
| 2006 | 74.9 |
| 2005 | 26.2 |
| 2004 | 16.7 |
Bioton Revenue, EBIT, Net Income PLBIOTN00029 · A0D9SD
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Bioton, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bioton from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bioton’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Bioton. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Bioton’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Bioton’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bioton’s growth potential.
Bioton Revenue, EBIT and net profit per share
| Date | Bioton Revenue | Bioton EBIT | Bioton Net Income |
|---|---|---|---|
| 2023 | 181.64 M PLN | 13.81 M PLN | 2.28 M PLN |
| 2022 | 233.16 M PLN | 27.93 M PLN | 1.42 M PLN |
| 2021 | 163.03 M PLN | 15.96 M PLN | 2.88 M PLN |
| 2020 | 221.79 M PLN | 30.24 M PLN | 33.92 M PLN |
| 2019 | 202.03 M PLN | -71.22 M PLN | -126.69 M PLN |
| 2018 | 241.17 M PLN | -50.52 M PLN | 26.27 M PLN |
| 2017 | 361.65 M PLN | 2.75 M PLN | -20.13 M PLN |
| 2016 | 277.61 M PLN | -10.83 M PLN | -28.57 M PLN |
| 2015 | 332.56 M PLN | 11.96 M PLN | -522.86 M PLN |
| 2014 | 377.3 M PLN | 21.77 M PLN | 3.68 M PLN |
| 2013 | 340.4 M PLN | 8.8 M PLN | -6.4 M PLN |
| 2012 | 406.3 M PLN | 66.5 M PLN | 37.8 M PLN |
| 2011 | 289 M PLN | -54.6 M PLN | -78.9 M PLN |
| 2010 | 378.6 M PLN | 48 M PLN | 117.2 M PLN |
| 2009 | 286.2 M PLN | -320.4 M PLN | -546.7 M PLN |
| 2008 | 293.5 M PLN | -32.1 M PLN | -218.9 M PLN |
| 2007 | 270.9 M PLN | 100.7 M PLN | 28.2 M PLN |
| 2006 | 215.5 M PLN | 74.9 M PLN | 93.8 M PLN |
| 2005 | 151.6 M PLN | 26.2 M PLN | 19.4 M PLN |
| 2004 | 128.8 M PLN | 16.7 M PLN | 5.8 M PLN |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 128.8 M PLN | 16.7 M PLN | 5.8 M PLN |
| 2005 | 151.6 M PLN | 26.2 M PLN | 19.4 M PLN |
| 2006 | 215.5 M PLN | 74.9 M PLN | 93.8 M PLN |
| 2007 | 270.9 M PLN | 100.7 M PLN | 28.2 M PLN |
| 2008 | 293.5 M PLN | -32.1 M PLN | -218.9 M PLN |
| 2009 | 286.2 M PLN | -320.4 M PLN | -546.7 M PLN |
| 2010 | 378.6 M PLN | 48 M PLN | 117.2 M PLN |
| 2011 | 289 M PLN | -54.6 M PLN | -78.9 M PLN |
| 2012 | 406.3 M PLN | 66.5 M PLN | 37.8 M PLN |
| 2013 | 340.4 M PLN | 8.8 M PLN | -6.4 M PLN |
| 2014 | 377.3 M PLN | 21.77 M PLN | 3.68 M PLN |
| 2015 | 332.56 M PLN | 11.96 M PLN | -522.86 M PLN |
| 2016 | 277.61 M PLN | -10.83 M PLN | -28.57 M PLN |
| 2017 | 361.65 M PLN | 2.75 M PLN | -20.13 M PLN |
| 2018 | 241.17 M PLN | -50.52 M PLN | 26.27 M PLN |
| 2019 | 202.03 M PLN | -71.22 M PLN | -126.69 M PLN |
| 2020 | 221.79 M PLN | 30.24 M PLN | 33.92 M PLN |
| 2021 | 163.03 M PLN | 15.96 M PLN | 2.88 M PLN |
| 2022 | 233.16 M PLN | 27.93 M PLN | 1.42 M PLN |
| 2023 | 181.64 M PLN | 13.81 M PLN | 2.28 M PLN |
Bioton stock margins PLBIOTN00029 · A0D9SD
The Bioton margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bioton. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bioton.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Bioton's sales revenue. A higher gross margin percentage indicates that the Bioton retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Bioton's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Bioton's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bioton's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bioton. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bioton's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Bioton Margin History
| Bioton Gross margin | Bioton Profit margin | Bioton EBIT margin | Bioton Profit margin |
|---|---|---|---|
| 2023 | 40.11 % | 7.61 % | 1.25 % |
| 2022 | 41.07 % | 11.98 % | 0.61 % |
| 2021 | 48.06 % | 9.79 % | 1.77 % |
| 2020 | 47.24 % | 13.63 % | 15.29 % |
| 2019 | 50.65 % | -35.25 % | -62.71 % |
| 2018 | 48.15 % | -20.95 % | 10.89 % |
| 2017 | 51.51 % | 0.76 % | -5.57 % |
| 2016 | 49.72 % | -3.9 % | -10.29 % |
| 2015 | 48.12 % | 3.6 % | -157.22 % |
| 2014 | 41.96 % | 5.77 % | 0.97 % |
| 2013 | 42.83 % | 2.59 % | -1.88 % |
| 2012 | 52.55 % | 16.37 % | 9.3 % |
| 2011 | 35.5 % | -18.89 % | -27.3 % |
| 2010 | 56.13 % | 12.68 % | 30.96 % |
| 2009 | 38.89 % | -111.95 % | -191.02 % |
| 2008 | 43.99 % | -10.94 % | -74.58 % |
| 2007 | 54.63 % | 37.17 % | 10.41 % |
| 2006 | 62.09 % | 34.76 % | 43.53 % |
| 2005 | 70.91 % | 17.28 % | 12.8 % |
| 2004 | 45.73 % | 12.97 % | 4.5 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 45.73 % | 12.97 % | 4.5 % |
| 2005 | 70.91 % | 17.28 % | 12.8 % |
| 2006 | 62.09 % | 34.76 % | 43.53 % |
| 2007 | 54.63 % | 37.17 % | 10.41 % |
| 2008 | 43.99 % | -10.94 % | -74.58 % |
| 2009 | 38.89 % | -111.95 % | -191.02 % |
| 2010 | 56.13 % | 12.68 % | 30.96 % |
| 2011 | 35.5 % | -18.89 % | -27.3 % |
| 2012 | 52.55 % | 16.37 % | 9.3 % |
| 2013 | 42.83 % | 2.59 % | -1.88 % |
| 2014 | 41.96 % | 5.77 % | 0.97 % |
| 2015 | 48.12 % | 3.6 % | -157.22 % |
| 2016 | 49.72 % | -3.9 % | -10.29 % |
| 2017 | 51.51 % | 0.76 % | -5.57 % |
| 2018 | 48.15 % | -20.95 % | 10.89 % |
| 2019 | 50.65 % | -35.25 % | -62.71 % |
| 2020 | 47.24 % | 13.63 % | 15.29 % |
| 2021 | 48.06 % | 9.79 % | 1.77 % |
| 2022 | 41.07 % | 11.98 % | 0.61 % |
| 2023 | 40.11 % | 7.61 % | 1.25 % |
Bioton Aktienanalyse
What does Bioton do?
Bioton SA is a leading Polish biotechnology company specializing in the development of innovative drugs, diagnostics, and medical devices. The company was founded in 1989 and has since achieved remarkable success. Bioton is headquartered in Poland and employs approximately 1000 people worldwide. The company is listed on the Warsaw Stock Exchange and is supported by renowned investors. Business model Bioton operates various business divisions, including research and development, production, sales, as well as marketing and distribution. The company collaborates closely with leading academic institutions and research organizations and invests significant resources in the development of new groundbreaking technologies and products. The company's products and services are distributed and used in over 60 countries worldwide. Divisions Bioton is divided into three main business sectors, including biopharmaceuticals, diagnostics, and medical devices. Biopharmaceuticals Bioton is known for its biopharmaceuticals, particularly insulin and insulin analogs. Insulin is a hormone produced by the body to regulate blood sugar levels. Bioton offers various insulin products, including human insulin, insulin glargine, and insulin aspart. These products are approved for the treatment of diabetes mellitus and are distributed in over 50 countries worldwide. Diagnostics Bioton is also involved in the development and production of diagnostics. The company offers various testing systems for the diagnosis of infectious diseases, allergies, and autoimmune diseases. The product line also includes in vitro diagnostics that are used for medical therapy monitoring and disease detection. Medical devices Bioton also manufactures and distributes medical devices such as insulin pumps and blood glucose meters. These devices are designed for people with diabetes and assist in accurate insulin dosing and blood sugar level monitoring. Products In addition to insulin and insulin analogs, Bioton also produces a wide range of other drugs, including growth hormones, as well as follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are used for the treatment of infertility. Bioton is also involved in the development of novel technologies such as RNA interference (RNAi) and genomic research. The company invests significantly in innovative research projects aimed at the development of groundbreaking drugs and therapies. In conclusion, Bioton SA is a highly innovative biotechnology company with a wide range of products and a focus on research and development. The company operates in the global market and collaborates closely with renowned institutions and research organizations. Bioton's business model is based on the development of innovative technologies and products aimed at improving the quality of life for people worldwide. Bioton ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Bioton's EBIT
Bioton's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Bioton's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Bioton's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Bioton’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Bioton stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Bioton.
How has the EBIT of Bioton developed in recent years?
The EBIT of Bioton has increased by -50.535% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Bioton?
The EBIT of Bioton is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Bioton pay?
Over the past 12 months, Bioton paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioton is expected to pay a dividend of 0 PLN.
What is the dividend yield of Bioton?
The current dividend yield of Bioton is .
When does Bioton pay dividends?
Bioton pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bioton?
Bioton paid dividends every year for the past 0 years.
What is the dividend of Bioton?
For the upcoming 12 months, dividends amounting to 0 PLN are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bioton located?
Bioton is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bioton kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bioton from 9/9/2024 amounting to 0 PLN, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.
When did Bioton pay the last dividend?
The last dividend was paid out on 9/9/2024.
What was the dividend of Bioton in the year 2023?
In the year 2023, Bioton distributed 0 PLN as dividends.
In which currency does Bioton pay out the dividend?
The dividends of Bioton are distributed in PLN.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bioton
Our stock analysis for Bioton Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioton Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
